sheet 4 uni

Patient Information Leaflets (PIL)

Overview of Patient Information Leaflets (PIL)

  • Type of Document: Provides information related to medications prescribed or available from pharmacies.

  • Purpose: To guide patients in safely using their medication by informing them about:

    • How to take it safely.

    • Possible side effects.

    • Potential interactions with other substances.

Content of Patient Information Leaflet (PIL)

1. Identification of the Medicine
  • The leaflet contains key identifiers for the medication including:

    • Trade Name: The name under which the medicine is marketed.

    • Active Substance(s): The chemical component(s) responsible for the medication's therapeutic effect.

    • Pharmaceutical Dosage Form: The specific form the medication takes (e.g., tablet, syrup, etc.).

    • Strength: The concentration of the active substance in the dosage form.

2. Therapeutic Indication
  • Describes the authorized conditions or diseases for which the medicine can be used.

3. Necessary Information Before Taking the Medicine
  • Important warnings and information to consider which includes:

    • Contraindications: Situations when the medicine should not be used.

    • Precautions and Warnings: Notably regarding allergies.

    • Drug Interactions: Possible interactions with other medicines or food.

    • Special Patient Groups: Information pertinent to vulnerable populations e.g., pregnant or nursing mothers.

    • Effects on Driving: Any impact the medicine may have on the patient's ability to operate a vehicle safely.

4. Dosage Instructions
  • Detailed guidance on:

    • How to Take the Medicine: Includes both method and route of administration.

    • Frequency of Administration: Specifies how often the medication should be taken.

    • Duration of Treatment: Outlines how long the treatment should continue.

    • Missed Doses: Instructions on what to do if a dose is missed.

    • Withdrawal Effects: Risks associated with suddenly stopping the medication.

5. Description of Side Effects
  • Comprehensive listing of potential side effects, which should be:

    • Ordered by seriousness.

    • Listed by frequency of occurrence.

    • Includes actions to take if side effects are experienced.

6. Additional Information
  • Other relevant details, such as:

    • Excipients: Non-active ingredients involved in the formulation (e.g., binders, coatings).

    • Registered Pack Size: The available packaging sizes for the medication.

    • Storage Conditions: Instructions on how to store the medicine safely.

    • Manufacturer's Details: Name and address of the company that produces the medication.

7. Date of Leaflet Preparation
  • The leaflet should include the date it was produced and must be subject to revision for updates.

8. Language Requirements
  • Official Language: The PIL must be produced in the official language of the governing member state; other languages may also be included.

  • Clarity and Legibility: It must be written in clear, understandable terms, ensuring legibility for the users.

Example of a Consumer Medicine Information (CMI)

  • A typical CMI might have the following features:

    • Accurate and up-to-date.

    • Clear headings, simple instructions, and straightforward explanations.

    • Inclusion of sections such as:

    • Product Name and Generic Name

    • Product Use and Formulation

    • Dosage Instructions

    • Side Effects and Other Precautions.

Example: Leaflet for Brufen (Ibuprofen 200mg Tablets)

  • Important Points to Note:

    • Read Carefully: Users must read the leaflet thoroughly as it contains critical information.

    • Keep the Leaflet: Recommended for future reference.

    • Consult Healthcare Professional: Users should contact their doctor or pharmacist if uncertain about their symptoms or if they worsen.

Specifics in the Leaflet:
  1. Indications: For mild to moderate pain relief, fever reduction, and anti-inflammatory uses.

    • Typically used for conditions such as arthritis and menstrual pain.

    • Effective usually within 30 minutes of administration.

  2. Contraindications Include:

    • Allergies to ibuprofen.

    • Late-stage pregnancy (last three months).

    • Severe liver, kidney disease, severe heart failure.

    • Previous stomach ulcers or bleeding issues.

  3. Food and Drink Considerations:

    • Can be taken with food or drinks; faster relief occurs on an empty stomach.

    • Caution with alcohol, which may amplify side effects.

  4. Pregnancy and Breastfeeding:

    • Not recommended in the last trimester of pregnancy.

    • Should be discussed with a healthcare professional if breastfeeding or planning pregnancy.

Conclusion

  • The PIL offers vital information designed to ensure patient safety and medication efficacy. Understanding and adhering to its contents is crucial for proper medication management.